2 results
Approved WMOCompleted
This study is designed to investigate the limiting effect on infarct size of high dose intravenous adenosine during primary angioplasty
Approved WMOCompleted
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.